Safety and Efficacy of Prostatic Artery Embolization in Patients with Refractory Lower Urinary Tract Symptoms after Transurethral Resection of the Prostate

Jake E. Radell; Samuel Z. Maron; Alex Sher; Vivian Bishay; Francis S. Nowakowski; Robert A. Lookstein; Ardeshir R. Rastinehad; Aaron M. Fischman

doi:10.1016/j.jvir.2021.07.003

Safety and Efficacy of Prostatic Artery Embolization in Patients with Refractory Lower Urinary Tract Symptoms after Transurethral Resection of the Prostate

Jake E. Radell
, Samuel Z. Maron
, Alex Sher
, Vivian Bishay
, Francis S. Nowakowski
, Robert A. Lookstein
, Ardeshir R. Rastinehad
, Aaron M. Fischman

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English
Pages (from-to)	1494-1496
Number of pages	3
Journal	Journal of Vascular and Interventional Radiology
Volume	32
Issue number	10
DOIs	https://doi.org/10.1016/j.jvir.2021.07.003
State	Published - Oct 2021

Access to Document

10.1016/j.jvir.2021.07.003

Cite this

Radell, J. E., Maron, S. Z., Sher, A., Bishay, V., Nowakowski, F. S., Lookstein, R. A., Rastinehad, A. R., & Fischman, A. M. (2021). Safety and Efficacy of Prostatic Artery Embolization in Patients with Refractory Lower Urinary Tract Symptoms after Transurethral Resection of the Prostate. Journal of Vascular and Interventional Radiology, 32(10), 1494-1496. https://doi.org/10.1016/j.jvir.2021.07.003

@article{05c23ad37fce4fe0a3ec3dd34f68dd96,

title = "Safety and Efficacy of Prostatic Artery Embolization in Patients with Refractory Lower Urinary Tract Symptoms after Transurethral Resection of the Prostate",

author = "Radell, \{Jake E.\} and Maron, \{Samuel Z.\} and Alex Sher and Vivian Bishay and Nowakowski, \{Francis S.\} and Lookstein, \{Robert A.\} and Rastinehad, \{Ardeshir R.\} and Fischman, \{Aaron M.\}",

note = "Funding Information: V.L.B. is a consultant for Boston Scientific. R.A.L. is a consultant for Medtronic and Boston Scientific; on the advisory board for Medtronic, Summa Medical, and Boston Scientific; and a speaker for Abbott Vascular. A.M.F. is a consultant for Terumo, Boston Scientific, and Johnson \& Johnson; on the advisory board for Perikinetics, Terumo, Embolx, Boston Scientific, and Johnson \& Johnson; a speaker for Boston Scientific and Terumo; receives research support for Boston Scientific; has a royalty agreement with Merit Medical; and is an investor in Adient Medical. None of the other authors have identified a conflict of interest.",

year = "2021",

month = oct,

doi = "10.1016/j.jvir.2021.07.003",

language = "English",

volume = "32",

pages = "1494--1496",

journal = "Journal of Vascular and Interventional Radiology",

issn = "1051-0443",

publisher = "Elsevier Inc.",

number = "10",

}

Radell, JE, Maron, SZ, Sher, A, Bishay, V, Nowakowski, FS, Lookstein, RA, Rastinehad, AR & Fischman, AM 2021, 'Safety and Efficacy of Prostatic Artery Embolization in Patients with Refractory Lower Urinary Tract Symptoms after Transurethral Resection of the Prostate', Journal of Vascular and Interventional Radiology, vol. 32, no. 10, pp. 1494-1496. https://doi.org/10.1016/j.jvir.2021.07.003

Safety and Efficacy of Prostatic Artery Embolization in Patients with Refractory Lower Urinary Tract Symptoms after Transurethral Resection of the Prostate. / Radell, Jake E.; Maron, Samuel Z.; Sher, Alex et al.
In: Journal of Vascular and Interventional Radiology, Vol. 32, No. 10, 10.2021, p. 1494-1496.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Safety and Efficacy of Prostatic Artery Embolization in Patients with Refractory Lower Urinary Tract Symptoms after Transurethral Resection of the Prostate

AU - Radell, Jake E.

AU - Maron, Samuel Z.

AU - Sher, Alex

AU - Bishay, Vivian

AU - Nowakowski, Francis S.

AU - Lookstein, Robert A.

AU - Rastinehad, Ardeshir R.

AU - Fischman, Aaron M.

N1 - Funding Information: V.L.B. is a consultant for Boston Scientific. R.A.L. is a consultant for Medtronic and Boston Scientific; on the advisory board for Medtronic, Summa Medical, and Boston Scientific; and a speaker for Abbott Vascular. A.M.F. is a consultant for Terumo, Boston Scientific, and Johnson & Johnson; on the advisory board for Perikinetics, Terumo, Embolx, Boston Scientific, and Johnson & Johnson; a speaker for Boston Scientific and Terumo; receives research support for Boston Scientific; has a royalty agreement with Merit Medical; and is an investor in Adient Medical. None of the other authors have identified a conflict of interest.

PY - 2021/10

Y1 - 2021/10

UR - https://www.scopus.com/pages/publications/85114378484

U2 - 10.1016/j.jvir.2021.07.003

DO - 10.1016/j.jvir.2021.07.003

M3 - Letter

C2 - 34271189

AN - SCOPUS:85114378484

SN - 1051-0443

VL - 32

SP - 1494

EP - 1496

JO - Journal of Vascular and Interventional Radiology

JF - Journal of Vascular and Interventional Radiology

IS - 10

ER -